Macropinocytosis inhibition attenuates profibrotic responses in lung fibroblasts and pulmonary fibrosis models
Journal of Clinical Investigation · 15.06.2026 · 136 (12)
DOI: 10.1172/jci197651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.04.2026. Verfasst von Ivan O Rosas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine. Hauptthemen laut MEDLINE: Fibroblasts, Pinocytosis, Lung, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, National Institute of Arthritis, Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disorder with limited treatment options. Macropinocytosis is one of the key cellular processes involved in nutrient consumption from the extracellular environment under stress conditions. Here, we studied the role of macropinocytosis in experimental pulmonary fibrosis models. We found that macropinocytosis is increased in human lung fibroblasts (HLFs) derived from patients with IPF. The inhibition of macropinocytosis with 5-(n-ethyl-n-isopropyl)-amiloride (EIPA) inhibited profibrotic responses in IPF-derived and TGF-β1–stimulated HLFs and reduced pulmonary fibrosis in bleomycin-injured (Bleo-injured) mice. EIPA exerted its antifibrotic effects by regulating amino acid uptake, mammalian target of rapamycin complex 1 (mTORC1) activation and mesenchyme homeobox1 ( MEOX1 ) expression in activated HLFs. Fittingly, genetic inhibition of macropinocytosis also ameliorated lung fibroblast activation and pulmonary fibrosis in mice. Using IPF-derived precision cut lung slices (PCLSs), we observed robust repression of profibrotic gene expression programs in EIPA-treated PCLSs across different fibroblast subpopulations. Finally, we found that imipramine (Imi), a tricyclic antidepressant approved by the FDA, effectively inhibited macropinocytosis and ameliorated profibrotic responses in lung fibroblasts, Bleo-injured mice, and IPF-derived PCLSs. Taken together, our results suggest that macropinocytosis inhibition can be considered as a potential therapeutic strategy to treat pulmonary fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine.
- Department of Molecular and Cellular Biology, and.
- Genomic and RNA Profiling Core, Baylor College of Medicine, Houston, Texas, USA.
- Department of Neurology, Pittsburgh Institute for Neurodegenerative Disorders, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Veterans Affairs Pittsburgh Health Care System, Geriatric Research, Educational and Clinical Center, Pittsburgh, Pennsylvania, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Förderung
- NIAMS NIH HHS
- NHLBI NIH HHS
- National Institute of Arthritis, Musculoskeletal and Skin Diseases
- National Heart, Lung and Blood Institute
Zitieren
APA
Rosas, I. O., McDowell-Sanchez, A. K., Sanchez, S., Cala-Garcia, J. D., Waich Cohen, A. R., Ruiz-Echartea, E., Ochsner, S. A., Kraushaar, D. C., Celada, L. J., Sun, D., Polverino, F., Coarfa, C., McKenna, N. J., & Tsoyi, K. (2026). Macropinocytosis inhibition attenuates profibrotic responses in lung fibroblasts and pulmonary fibrosis models. Journal of Clinical Investigation, 136(12). https://doi.org/10.1172/jci197651
Vancouver
Rosas IO, McDowell-Sanchez AK, Sanchez S, Cala-Garcia JD, Waich Cohen AR, Ruiz-Echartea E, et al. Macropinocytosis inhibition attenuates profibrotic responses in lung fibroblasts and pulmonary fibrosis models. Journal of Clinical Investigation. 2026;136(12). doi:10.1172/jci197651
BibTeX
@article{Rosas2026,
author = {Rosas, Ivan O and McDowell-Sanchez, Aaron K and Sanchez, Santiago and Cala-Garcia, Juan D and Waich Cohen, Alan R and Ruiz-Echartea, Elisa and Ochsner, Scott A and Kraushaar, Daniel C and Celada, Lindsay J and Sun, Dandan and Polverino, Francesca and Coarfa, Cristian and McKenna, Neil J and Tsoyi, Konstantin},
title = {Macropinocytosis inhibition attenuates profibrotic responses in lung fibroblasts and pulmonary fibrosis models},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {12},
doi = {10.1172/jci197651}
}
EUVIMED